About

About SyntheticGestalt KK "DRUG DISCOVERY REIMAGINED: 90% LESS COST, 75% LESS TIME" [PIONEERING MOLECULAR AI INNOVATION] SyntheticGestalt has developed the world's largest molecule-specialized AI foundation model, revolutionizing drug discovery and molecular design across industries. Founded in 2018 in Tokyo, we're addressing a critical challenge: early-stage pharmaceutical R&D consumes 40% of total drug development costs while traditional AI approaches struggle with limited datasets and technical barriers. Our proprietary SG4D10B foundation model, trained on 10 billion compounds across 100+ tasks, captures four-dimensional molecular information for unprecedented prediction accuracy. Unlike repurposed language models, our architecture was built specifically for molecular science, delivering superior performance even with minimal training data. [PROVEN RESULTS ACROSS INDUSTRIES] Our technology has delivered transformative ROI through real-world applications: * Pharmaceutical Partners: Virtual screening of 38 billion compounds identified a novel MKNK2 inhibitor in just 3 months instead of 12, with 90% cost reduction * Beverage Industry: Reduced discovery timelines for functional ingredients from 5 years to 6 months, identifying 10 active candidates from a 250M compound library * Environmental Solutions: Discovered novel PET-degrading enzymes outperforming existing plastic recycling solutions Chemical Manufacturing: Identified enzymatic pathways enabling sustainable production processes These successes demonstrate our consistent ability to accelerate molecular discovery by 75% while reducing costs by 90% compared to traditional approaches. [FLEXIBLE BUSINESS MODELS] SyntheticGestalt offers engagement options tailored to client needs: * Foundation Model Access: Enterprise subscription to SG4D10B via AWS and Google Cloud Marketplaces * Strategic Research Collaborations: Fixed-fee discovery programs or milestone-based development partnerships * Compound Discovery: Direct IP transfer of novel molecules identified through our AI platform Our multidisciplinary team of AI experts, medicinal chemists, and computational biologists works directly with partners to maximize value delivery. [UNIQUE TECHNOLOGY ADVANTAGES] What sets our approach apart: * World's Largest Molecular AI: Trained on 10 billion compounds—orders of magnitude beyond competitors * True 4D Representation: Captures complete structural and electronic properties for superior prediction accuracy * Minimal Data Requirements: Achieves high performance with significantly smaller datasets than traditional AI * Cross-Domain Applications: From small molecule drugs to industrial enzymes, materials, and beyond [APPLICATIONS BEYOND PHARMACEUTICALS] While pharmaceutical applications deliver dramatic ROI, our technology drives innovation across multiple industries: * Chemical Manufacturing: Enzyme discovery for greener production processes * Materials Science: Novel materials with precisely engineered properties * Agrichemicals: Safer, more effective crop protection solutions * Food & Beverage: Functional ingredients with targeted properties * Fragrance: Prediction of sensory characteristics in aroma compounds [GLOBAL EXPANSION] With successful partnerships in Japan with major corporations including Enamine and Asahi Group, we're now expanding internationally, raising Series B funding to accelerate U.S. market entry. Our vision extends to designing multi-component molecular systems, optimizing synthetic pathways, predicting complex biological interactions, and creating autonomous discovery platforms—dramatically accelerating scientific innovation. [PARTNER WITH US AT BIO INTERNATIONAL 2025] Visit us at Booth #2265 in the Japan Pavilion or schedule a meeting through the BIO Partnering System to discuss: * How our technology can transform your specific R&D challenges * Collaborative research opportunities * Foundation model access options Join the organizations already leveraging our technology to achieve breakthrough results in molecular discovery with 90% less cost and 75% less time. [CONTACT INFORMATION] Location: Japan Pavilion, Booth #2265 Website: https://syntheticgestalt.com/en Email: d.morohashi@syntheticgestalt.com Partnering Contact: Daisuke Morohashi, Head of AI Business